Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Otsuka Pharmaceutical

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Looking for a perfect list of funds?

Get recommendations from our smart algorithm

Get the list
Total investments 8
Average round size
info
The average size of a deal this fund participated in
$94M
Portfolio companies 7
Rounds per year 0.14
Lead investments 1
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.12
Exits 2
Key employees Soon

Areas of investment

  • Health Care
  • Therapeutics
  • Medical Device
  • Biotechnology
  • Pharmaceutical

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Otsuka Pharmaceutical:
Typical Co-investors
Otsuka Pharmaceutical is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Otsuka Pharmaceutical:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
101 Startups Barcelona, Catalonia, Spain
Alexa Next Stage, powered by Techstars -
American Industrial Partners New York, New York, United States
Bohong Jijin China, Guangdong, Shenzhen
Collins Community Credit Union Cedar Rapids, Iowa, United States
Contents innovation Program Japan, Tokyo
Crossfire Holdings -
Jiaxing Xiaoyuan Chuangye Touzi Hehuo Qiye China, Jiaxing, Zhejiang
JP Asia Capital Partners Central, Central Region, Singapore
Livesense Japan, Tokyo
M5Invest Partners Pennsylvania, United States, Villanova
Mingde Zhiyuan Touzi China, Guangdong, Tianjin
Neusoft Group China, Liaoning, Shenyang
Pimpernel Holdings -
Portag3 Ventures Canada, Ontario, Toronto
RevRoad Provo, United States, Utah
Siam Alpha Equity -
Taiwan Special Opportunities Fund III -
Tudor Growth Equity Boston, Massachusetts, United States

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

OE Therapeutics

Therapeutics
$26M03 Aug 2022 New Haven, Connecticut, United States

Renascience

Clinical Trials
Health Care
Health Diagnostics
$455K11 Mar 2019 Chiyoda

Click Therapeutics

Biotechnology
Health Care
Information Technology
Medical Device
Other Healthcare Technology Systems
Pharmaceutical
Therapeutics
$302M11 Dec 2018 New York, United States

PeptiStar

Business Information Systems
Document Management
Information Services
Manufacturing
$182M18 Apr 2018 Settsu, Osaka Prefecture, Japan

SomaLogic

Biotechnology
Health Care
Health Diagnostics
Life Science
Medical Device
Pharmaceutical
$200M03 Jan 2018 Boulder, Colorado, United States

Megakaryon Corporation

Health Care
Medical
Product Research
$33M25 Dec 2017 Kyoto, Kyoto Prefecture, Japan

ReCor Medical

Health Care
Medical
Therapeutics
$15M13 Apr 2015 Palo Alto, California, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Otsuka Pharmaceutical?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: